acuteadditionadenocarcinomaadjuvantadolescentsadultsadvancedalkamlamonganalysisannualanotherarticleascoassessmentassociatedautologousbasedbetterbevacizumabbiologybiomarkerbiopsybrafbrainbrca1breastcancercancerscarcinomacardiaccarecellcetuximabchemoradiationchemotherapychildhoodchildrencoloncolorectalcombinationdatadecisiondetectiondiagnoseddiffusediscussiondiseasedisparitiesdondosedoubleearlyefficacyegfrendendometrialevolutionfinancialfirstfollicularfollowfollowinggastricgermlinehematopoieticher2highhodgkinhormonehoursiiiimagingimmuneimpactimplicationsimportanceimproveimprovesinducedinhibitioninhibitorinsightsinvasivelargelateleukemialifelikelinelocallylonglowlunglymphoblasticlymphomalymphomasmaintenancemanagementmedicalmedicaremeetingmelanomametastasesmetastaticminimalmolecularmortalitymrdmultimultiplemutantmutatedmutationmutationsmyeloidmyelomanegativeneoadjuvantnivolumabnodenovelnsclcolderoptionsoutcomeoutcomesovarianpancreaticpatientpatientspediatricpembrolizumabphasepluspositiveprimaryprimeprognosticpromiseprostatequalityquestionracialradiationradiotherapyrarereadyreceivingreceptorrectalrecurrencerecurrentrefractoryrelapsedrelatedresearchresectableresidualresponseresultsriskrituximabrolesafetyscreeningsecondsettingsinglesmallsmokingstagestemstudysurgerysurvivalsurvivorssystemictermtestingtherapeutictherapytimetoxicitytransplanttransplantationtrastuzumabtreatedtreatmenttrialtrialstumortumorsuseusingvalueversuswomenyoung